Chen X, Zhang FH, Chen QE, Wang YY, Wang YL, He JC, Zhou J. The clinical significance of CDK₁ expression in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2015 Jan 1;20 (1):e7-12.

doi:10.4317/medoral.19841

http://dx.doi.org/doi:10.4317/medoral.19841

1. Jemal A. Global burden of cancer: opportunities for prevention. Lancet. 2012;380:1797-9.
http://dx.doi.org/10.1016/S0140-6736(12)61688-2

2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71-96.
http://dx.doi.org/10.3322/CA.2007.0010

3. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14:243-50.

4. Goranov AI, Amon A. Growth and division-not a one way road. Curr Opin Cell Biol. 2010;22:795-800.
http://dx.doi.org/10.1016/j.ceb.2010.06.004

5. Li JM, Brooks G. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?. Eur Heart J. 1999;20:406-20.
http://dx.doi.org/10.1053/euhj.1998.1308

6. van Leuken R, Clijsters L, Wolthuis R. To cell cycle, swing the APC/C. Biochim Biophys Acta. 2008;1786:49-59.

7. Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med. 2002;13:51-61.
http://dx.doi.org/10.1177/154411130201300106

8. Saito T, Nakajima T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med. 1999;28:226-32.
http://dx.doi.org/10.1111/j.1600-0714.1999.tb02029.x

9. Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res. 2002;8:817-22.

10. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471-4.
http://dx.doi.org/10.1245/s10434-010-0985-4

11. World Health Organization. World Health Organization Classification of Tumours: Pathology and Genetics of.Head and Neck Tumours.2005.International Agency for Research on Cancer (IARC) Press. p. 1-360.

12. Wada S, Yue L, Furuta I. Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma. Oral Oncol. 2004;40:164-9.
http://dx.doi.org/10.1016/S1368-8375(03)00146-5

13. O'Brien PC, Zhang D, Bailey KR. Semi-parametric and non-parametric methods for clinical trials with incomplete data. Stat Med. 2005;24:341-58.
http://dx.doi.org/10.1002/sim.1963

14. Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87:14-32.
http://dx.doi.org/10.1177/154405910808700104

15. Fu JY, Gao J, Zhang ZY, Zheng JW, Luo JF, Zhong LP, et al. Tea consumption and the risk of oral cancer incidence: a case-control study from China. Oral Oncol. 2013;49:918-22.
http://dx.doi.org/10.1016/j.oraloncology.2013.05.002

16. Coleman MP, Rachet B, Woods LM, Mitry E, Riga M, Cooper N, et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer. 2004;90:1367-73.
http://dx.doi.org/10.1038/sj.bjc.6601696

17. Zhang J, Cao W, Xu Q, Chen WT. The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumour metastasis. J Clin Pathol. 2010;64:25-9.
http://dx.doi.org/10.1136/jcp.2010.082404

18. Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg. 2008;46:1-5.
http://dx.doi.org/10.1016/j.bjoms.2007.08.006

19. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
http://dx.doi.org/10.3322/caac.20107

20. Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol. 2001;2:698-704.
http://dx.doi.org/10.1016/S1470-2045(01)00560-5

21. Jorgensen P, Tyers M. How cells coordinate growth and division. Curr Biol. 2004;14:R1014-27.
http://dx.doi.org/10.1016/j.cub.2004.11.027

22. Goodger NM, Gannon J, Hunt T, Morgan PR. The localization of p34cdc2 in the cells of normal, hyperplastic, and malignant epithelial and lymphoid tissues of the oral cavity. J Pathol. 1996;178:422-8.
http://dx.doi.org/10.1002/(SICI)1096-9896(199604)178:4<422::AID-PATH497>3.0.CO;2-2